Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IDXX | US
5.00
0.89%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
565.93
556.85
567.94
552.00
IDEXX Laboratories Inc. develops manufactures and distributes products primarily for the companion animal veterinary livestock and poultry dairy and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock Poultry and Dairy. It also provides point-of-care veterinary diagnostic products including instruments consumables and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community. In addition the company offers diagnostic and health-monitoring products for livestock poultry and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry blood and urine chemistry hematology immunoassay urinalysis and coagulation analyzers; and SNAP rapid assays test kits. Further it provides Colilert Colilert-18 and Colisure tests which detect the presence of total coliforms and E. coli in water; Enterolert Pseudalert Filta-Max and Filta-Max xpress Legiolert and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing customer service sales and technical service groups as well as through independent distributors and other resellers. IDEXX Laboratories Inc. was incorporated in 1983 and is headquartered in Westbrook Maine.
View LessStrength based on increasing price with high volume
Largecap (10B - 200B USD)
Strong Operating Margin (> 25%)
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.1%1 month
30.5%3 months
30.6%6 months
35.4%45.46
40.98
24.16
0.68
0.31
31.92
10.26
4.88
1.27B
46.58B
46.58B
-
32.41
-8.60
6.40
63.25
6.31
3.68
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
42.52
Range1M
57.31
Range3M
157.31
Rel. volume
1.15
Price X volume
326.50M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc | A | Diagnostics & Research | 115.55 | 33.20B | 0.99% | 28.92 | 49.67% |
| GE HealthCare Technologies Inc. | GEHC | Health Information Services | 68.83 | 31.43B | -1.52% | 26.40 | 123.86% |
| IQVIA Holdings Inc | IQV | Diagnostics & Research | 162.28 | 29.58B | 1.00% | 30.78 | 200.33% |
| Mettler-Toledo International Inc | MTD | Diagnostics & Research | 1282.45 | 27.21B | 1.43% | 37.74 | -1347.12% |
| Veeva Systems Inc | VEEV | Health Information Services | 161.13 | 26.09B | 3.19% | 59.18 | 1.04% |
| Koninklijke Philips N.V | PHG | Diagnostics & Research | 27.47 | 25.60B | -0.58% | n/a | 69.56% |
| Natera Inc | NTRA | Diagnostics & Research | 203.75 | 25.20B | 1.30% | n/a | 52.31% |
| DexCom Inc | DXCM | Diagnostics & Research | 61.57 | 24.67B | -1.80% | 44.96 | 106.57% |
| Laboratory Corporation of America Holdings | LH | Diagnostics & Research | 263.8 | 22.15B | -0.42% | 40.18 | 74.63% |
| Quest Diagnostics Incorporated | DGX | Diagnostics & Research | 196.27 | 21.85B | -1.63% | 20.22 | 76.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Netflix Inc | NFLX | Media - Diversified | 92.44 | 39.67B | -0.41% | 43.23 | 70.34% |
| Live Nation Entertainment Inc | LYV | Media - Diversified | 156.64 | 36.36B | 2.24% | 105.45 | -18562.20% |
| PPL Corporation | PPL | Building Products & Equipment | 38.75 | 28.59B | 0.54% | 28.90 | 114.80% |
| Twenty-First Century Fox Inc | FOXA | Media - Diversified | 62.85 | 27.58B | -2.60% | 13.57 | 76.09% |
| Twenty-First Century Fox Inc | FOX | Media - Diversified | 56.17 | 26.86B | -2.72% | 12.45 | 76.09% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.48 | 3.49B | -0.42% | 27.93 | 934.91% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 31.92 | 12.67 | Expensive |
| Ent. to Revenue | 10.26 | 44.00 | Cheaper |
| PE Ratio | 45.46 | 40.09 | Par |
| Price to Book | 24.16 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 30.59 | 59.59 | Lower Risk |
| Debt to Equity | 0.68 | -14.36 | Expensive |
| Debt to Assets | 0.31 | 0.34 | Par |
| Market Cap | 46.58B | 13.71B | Market Leader |